|
|
Bristol myers Squibb Company (BMY) |
|
|
|
| |
BMY's Revenue Growth by Quarter and Year
Bristol Myers Squibb's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BMY Revenue (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
11,406.00
|
11,985.00
|
11,068.00
|
| III Quarter |
September |
-
|
11,218.00
|
11,624.00
|
10,540.00
|
| II Quarter |
June |
11,226.00
|
11,887.00
|
11,703.00
|
10,129.00
|
| I Quarter |
March |
11,337.00
|
11,648.00
|
11,073.00
|
10,781.00
|
| FY |
|
22,563.00
|
46,159.00
|
46,385.00
|
42,518.00
|
| BMY Revenue second quarter 2023 Y/Y Growth Comment |
Bristol Myers Squibb Company reported decrease in Revenue in the second quarter 2023 by -5.56% to $ 11,226.00 millions, from the same quarter in 2022.
The decrease in the second quarter 2023 Bristol Myers Squibb Company's Revenue compares unfavorably to the Company's average Revenue growth of 5.89%.
Looking into second quarter 2023 results within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Revenue growth. While Bristol Myers Squibb Company' s Revenue decline of -5.56% ranks overall at the positon no. 373 in the second quarter 2023.
|
| BMY Revenue ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
-4.83 % |
8.29 % |
39.31 % |
| III Quarter |
September |
- |
-3.49 % |
10.28 % |
75.46 % |
| II Quarter |
June |
-5.56 % |
1.57 % |
15.54 % |
61.47 % |
| I Quarter |
March |
-2.67 % |
5.19 % |
2.71 % |
82.11 % |
| FY |
|
- |
-0.49 % |
9.09 % |
62.62 % |
BMY Revenue (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
1.68 % |
3.11 % |
5.01 % |
| III Quarter |
September |
- |
-5.63 % |
-0.68 % |
4.06 % |
| II Quarter |
June |
-0.98 % |
2.05 % |
5.69 % |
-6.05 % |
| I Quarter |
March |
-0.6 % |
-2.81 % |
0.05 % |
35.7 % |
| FY (Year on Year) |
|
- |
-0.49 % |
9.09 % |
62.62 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 62.97 % |
5.89 % |
-24.59 % |
| (Sep 30 2020) |
|
(March 31, 2013) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 62.97 % |
5.89 % |
-24.59 % |
| (Sep 30 2020) |
|
(March 31, 2013) |
|
| Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Bristol Myers Squibb's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 35.7 % |
1.35 % |
-15.91 % |
| (Mar 31 2020) |
|
|
| BMY's II. Quarter Q/Q Revenue Comment |
In the II. Quarter 2023 Bristol Myers Squibb Company realized decrease in Revenue from the first quarter by -0.98% to $ 11,226.00 millions, from $ 11,337.00 millions achived in the previous quarter.
Albeit seasonal influence normally elevate II. Quarter 2023 results, it simply was not substantial to salvage BMY's II. Quarter 2023 outcome, Lucas L. Anderson, market expert situated in Toronto said and continued that average quarter on quarter Revenue growth is at 1.35% for Bristol Myers Squibb.
Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb's Revenue growth quarter on quarter, overall rank is 353. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 35.7 % |
1.35 % |
-15.91 % |
| (Mar 31 2020) |
|
|
| BMY's II. Quarter Q/Q Revenue Comment |
In the II. Quarter 2023 Bristol Myers Squibb Company realized decrease in Revenue from the first quarter by -0.98% to $ 11,226.00 millions, from $ 11,337.00 millions achived in the previous quarter.
Albeit cyclical influence commonly elevate II. Quarter 2023 performance, that plainly could not be sufficient to salvage BMY's performance, Lucas L. Anderson, market expert situated in Toronto wrote and continued that average sequential Revenue growth is at 1.35% for Bristol Myers Squibb.
Within Major Pharmaceutical Preparations industry 5 other companies have achieved higher Revenue quarter on quarter growth. While Bristol Myers Squibb's Revenue growth quarter on quarter, overall rank is 353. |
|
Bristol Myers Squibb's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
12 Months Ending
(Jun 30 2022) |
| Cumulative Revenue 12 Months Ending |
$ 45,187.00 |
$ 45,848.00 |
$ 46,159.00 |
$ 46,738.00 |
$ 47,144.00 |
| Y / Y Revenue Growth (TTM) |
-4.15 % |
-2.37 % |
-0.49 % |
2.79 % |
6.22 % |
| Year on Year Revenue Growth Overall
Ranking |
# 288 |
# 216 |
# 1343 |
# 2328 |
# 330 |
| Seqeuential Revenue Change (TTM) |
-1.44 % |
-0.67 % |
-1.24 % |
-0.86 % |
0.39 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 2214 |
# 326 |
# 1788 |
# 225 |
# 365 |
| Cumulative Revenue growth
Comment |
Bristol Myers Squibb's cumulative 12 months Revenue continue to decrease, but on the faster rate at -4.15% year on year, at Jun 30 2023 compare to the -2.37% decrease at Mar 31 2023. If the Bristol Myers Squibb's fiscal year would end at Jun 30 2023, annual Revenue would be $45,187 millions.
Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 216 to 288. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.89 % |
-24.59 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.89 % |
-24.59 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 127 |
| Sector |
# 349 |
| S&P 500 |
# 2214 |
|
| Cumulative Revenue growth
Comment |
Bristol Myers Squibb's cumulative 12 months Revenue continue to decrease, but on the faster rate at -4.15% year on year, at Jun 30 2023 compare to the -2.37% decrease at Mar 31 2023. If the Bristol Myers Squibb's fiscal year would end at Jun 30 2023, annual Revenue would be $45,187 millions.
Among companies within the Healthcare sector 16 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 216 to 288. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.89 % |
-24.59 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
62.97 % |
5.89 % |
-24.59 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 127 |
| Sector |
# 349 |
| S&P 500 |
# 2214 |
|
